Stay updated on BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial page.

Latest updates to the BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov record for a completed Phase 3 melanoma study is now displayed instead of an error page. It provides the study design, participant eligibility, locations, outcome measures, and supporting documents.SummaryDifference74%

- Check11 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check18 days agoChange DetectedA site-wide banner announces NIH website updates and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check25 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check39 days agoChange DetectedThe page now displays a 403 Forbidden message and a Home link instead of the study record content.SummaryDifference0.5%

Stay in the know with updates to BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial page.